Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2902587298;87299;87300 chr2:178558386;178558385;178558384chr2:179423113;179423112;179423111
N2AB2738482375;82376;82377 chr2:178558386;178558385;178558384chr2:179423113;179423112;179423111
N2A2645779594;79595;79596 chr2:178558386;178558385;178558384chr2:179423113;179423112;179423111
N2B1996060103;60104;60105 chr2:178558386;178558385;178558384chr2:179423113;179423112;179423111
Novex-12008560478;60479;60480 chr2:178558386;178558385;178558384chr2:179423113;179423112;179423111
Novex-22015260679;60680;60681 chr2:178558386;178558385;178558384chr2:179423113;179423112;179423111
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAC
  • RefSeq wild type template codon: CTG
  • Domain: Fn3-99
  • Domain position: 84
  • Structural Position: 119
  • Q(SASA): 0.6763
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/H rs1702323691 None 1.0 N 0.705 0.368 0.307648195649 gnomAD-3.1.2 6.57E-06 None None None None I None 2.41E-05 0 0 0 0 None 0 0 0 0 0
D/H rs1702323691 None 1.0 N 0.705 0.368 0.307648195649 gnomAD-4.0.0 2.56268E-06 None None None None I None 3.38238E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.1511 likely_benign 0.1604 benign -0.669 Destabilizing 0.998 D 0.709 prob.delet. N 0.455622189 None None I
D/C 0.6458 likely_pathogenic 0.6604 pathogenic -0.285 Destabilizing 1.0 D 0.748 deleterious None None None None I
D/E 0.1156 likely_benign 0.1224 benign -0.498 Destabilizing 0.4 N 0.228 neutral N 0.396573885 None None I
D/F 0.5246 ambiguous 0.5575 ambiguous -0.21 Destabilizing 1.0 D 0.746 deleterious None None None None I
D/G 0.2557 likely_benign 0.2696 benign -0.957 Destabilizing 0.998 D 0.716 prob.delet. N 0.517228008 None None I
D/H 0.3113 likely_benign 0.3267 benign -0.19 Destabilizing 1.0 D 0.705 prob.neutral N 0.509283315 None None I
D/I 0.2736 likely_benign 0.2895 benign 0.076 Stabilizing 1.0 D 0.771 deleterious None None None None I
D/K 0.3553 ambiguous 0.3676 ambiguous -0.155 Destabilizing 1.0 D 0.717 prob.delet. None None None None I
D/L 0.2926 likely_benign 0.3117 benign 0.076 Stabilizing 1.0 D 0.759 deleterious None None None None I
D/M 0.4807 ambiguous 0.5029 ambiguous 0.348 Stabilizing 1.0 D 0.738 prob.delet. None None None None I
D/N 0.1143 likely_benign 0.115 benign -0.632 Destabilizing 0.999 D 0.72 prob.delet. N 0.515921286 None None I
D/P 0.5042 ambiguous 0.5144 ambiguous -0.15 Destabilizing 0.999 D 0.755 deleterious None None None None I
D/Q 0.2826 likely_benign 0.3044 benign -0.538 Destabilizing 1.0 D 0.738 prob.delet. None None None None I
D/R 0.4424 ambiguous 0.4619 ambiguous 0.148 Stabilizing 1.0 D 0.771 deleterious None None None None I
D/S 0.1206 likely_benign 0.1271 benign -0.802 Destabilizing 0.998 D 0.684 prob.neutral None None None None I
D/T 0.2312 likely_benign 0.2403 benign -0.565 Destabilizing 0.999 D 0.714 prob.delet. None None None None I
D/V 0.1627 likely_benign 0.1731 benign -0.15 Destabilizing 0.999 D 0.759 deleterious N 0.509283315 None None I
D/W 0.8925 likely_pathogenic 0.9065 pathogenic 0.07 Stabilizing 1.0 D 0.754 deleterious None None None None I
D/Y 0.2512 likely_benign 0.265 benign 0.054 Stabilizing 1.0 D 0.747 deleterious N 0.482155659 None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.